Escalante Bioscience
San Francisco, US · Founded 2024 · Delaware corporation
Founders & leadership
AT
Akshay TambeNamed on SEC filing
AD
April D SchleckNamed on SEC filing
CH
Ching-Yun HsuNamed on SEC filing
NR
Nicholas R BoydNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.7M disclosed across 1 round · 2024
▶$6.7MraisedMay 2024 · 17 investors · Other Health CareRule 506(b)
▶$6.7MraisedMay 2024 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Akshay TambeDirector
- April D SchleckExecutive Officer, Director
- Ching-Yun HsuExecutive Officer, Director
- Nicholas R BoydDirector
- Offering amount
- $6.7M
- Amount sold
- $6.7M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Escalante Bioscience raised?
- Escalante Bioscience has disclosed $6.7M raised across 1 round.
- Where is Escalante Bioscience headquartered?
- Escalante Bioscience is headquartered in San Francisco, US.